While commercial cell and gene therapies are transforming medicine, academic medical centers face a massive, operational burden when delivering them. From juggling separate vendor software portals to guiding lost couriers carrying $3M therapies through hospital corridors, point-of-care delivery is fraught with administrative and physical friction.


In this episode of Out of the Lab, host Nico Crudele sits down with Dr. Patrick Hanley, Director of Cellular Therapy at Children's National Hospital. Together, they break down the real-world disconnects between commercial biopharma developers, hospital stem cell labs, and final patient delivery.

Key Topics Discussed:

  • Portal Fatigue: Why custom vendor portals, IT approvals, and unique qualification forms create immense administrative overhead for hospital staff.

  • The Hospital Shipping Strain: How commercial manufacturing delays and re-collections caused a hospital cell lab's shipment volume to explode from near zero to 90+ shipments annually.

  • Tacit Knowledge in Tech Transfer: How terms like "gently resuspend" or "ice-cold PBS" lead to cracked flasks, variable yields, and batch failures.

  • Decentralized Manufacturing & Regulatory Pathways: Exploring rapid BLA mechanisms and point-of-care models for rare pediatric diseases.

  • Training Beyond Hardware: Why the industry over-indexes on equipment training while ignoring essential quality soft skills like deviation writing and root-cause analysis.

Brought to you by Method Made. Accelerate your tech transfer by up to six months using video SOPs to capture technical nuance. Download the free Tech Transfer Failure Modes and Effects Analysis at methodmade.ca.

Podden och tillhörande omslagsbild på den här sidan tillhör Nicholas (Nico) Crudele. Innehållet i podden är skapat av Nicholas (Nico) Crudele och inte av, eller tillsammans med, Poddtoppen.